Xiaojun Wu

2.4k total citations · 1 hit paper
89 papers, 1.7k citations indexed

About

Xiaojun Wu is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaojun Wu has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 33 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaojun Wu's work include Colorectal Cancer Treatments and Studies (24 papers), Colorectal Cancer Surgical Treatments (21 papers) and Gastric Cancer Management and Outcomes (18 papers). Xiaojun Wu is often cited by papers focused on Colorectal Cancer Treatments and Studies (24 papers), Colorectal Cancer Surgical Treatments (21 papers) and Gastric Cancer Management and Outcomes (18 papers). Xiaojun Wu collaborates with scholars based in China, United States and Norway. Xiaojun Wu's co-authors include Zhizhong Pan, Zhenhai Lu, Jianhong Peng, Junzhong Lin, Yujing Fang, Desen Wan, Peirong Ding, Li Li, Qingjian Ou and Wuguo Deng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaojun Wu

87 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer

2023 240 citations Weihao Li, Chi Zhou et al. Autophagy profile →

Peers

Countries citing papers authored by Xiaojun Wu

Since Specialization

Citations

This map shows the geographic impact of Xiaojun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Wu more than expected).

Fields of papers citing papers by Xiaojun Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Wu. The network helps show where Xiaojun Wu may publish in the future.

Co-authorship network of co-authors of Xiaojun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Wu. A scholar is included among the top collaborators of Xiaojun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Wu. Xiaojun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning-based return-to-work assessment system for acute myocardial infarction patients within 12 months 2025 ·Heart & Lung ·Xiaojun Wu, Shiyu Wang, (unknown), Xianghui Zheng, Xinyu Hou, Zhuozhong Wang, Qifeng Li, Qi Liu, (unknown), Yang Zheng, Jian Wu, (unknown)	0
2	Effects of three orthodontic retainers on periodontal pathogens and periodontal parameters 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), Xiaojun Wu, Guilin Wu, Xian‐Tao Zeng	2
3	Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial 2023 ·Cancer Medicine ·Shuang Liu, (unknown), (unknown), Shoumin Bai, Xiaojun Wu, (unknown), (unknown), Haina Yu, Qiaoxuan Wang, Hui Chang, Zhifan Zeng, Peiqiang Cai, Zhizhong Pan, Yuanhong Gao, Gong Chen, Weiwei Xiao	2
4	554MO Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX in RAS wild-type patients with initially unresectable colorectal liver metastases: The TRICE randomized clinical trial 2023 ·Annals of Oncology ·Yong Li, De‐Shen Wang, Chao Ren, Li Ss, (unknown), Xiaojun Wu, Jiadong Xiao, Yunfei Yuan, (unknown), (unknown), Zhi‐Qiang Wang, Fang Wang, Zhizhong Pan, (unknown), (unknown), Ling‐Yu Wang, Tao Chen, Tianshu Liu, Ying Yuan, (unknown)	1
5	Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer breakdown → 2023 ·Autophagy ·Weihao Li, Chi Zhou, Long Yu, Zhenlin Hou, Huashan Liu, Ling-Heng Kong, Yanbo Xu, Jiahua He, Lan Jin, Qingjian Ou, Yujing Fang, Zhenhai Lu, Xiaojun Wu, Zhizhong Pan, Jianhong Peng, Junzhong Lin	240
6	High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer 2022 ·Radiation Oncology ·Qiaoxuan Wang, Shu Zhang, Weiwei Xiao, (unknown), Hui Chang, Zhifan Zeng, Peiqiang Cai, Zhenhai Lu, Gong Chen, Peirong Ding, Zhizhong Pan, Xiaojun Wu, Yuanhong Gao	1
7	Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer 2021 ·Cancer Cell International ·Jianhong Peng, Weihao Li, Wenhua Fan, Rongxin Zhang, Xinyue Li, Binyi Xiao, (unknown), Desen Wan, Zhizhong Pan, Junzhong Lin, Xiaojun Wu	6
8	Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer 2021 ·Journal of Hematology & Oncology ·Gong Chen, Junjie Peng, Qian Xiao, Hao‐Xiang Wu, Xiaojun Wu, Fulong Wang, Li Li, Peirong Ding, Qi Zhao, Yaqi Li, Da Wang, Yang Shao, Hua Bao, Zhizhong Pan, Kefeng Ding, Sanjun Cai, Feng Wang, Rui‐Hua Xu	107
9	Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection 2021 ·BMC Cancer ·Yan Yuan, Weiwei Xiao, Weihao Xie, Peiqiang Cai, Qiaoxuan Wang, Hui Chang, (unknown), Wenhao Zhou, Zhifan Zeng, Xiaojun Wu, Qing Liu, Li Li, Rong Zhang, Yuanhong Gao	13
10	Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China 2021 ·Frontiers in Surgery ·Jianhong Peng, Weihao Li, Jinghua Tang, Yuan Li, Xueying Li, Xiaojun Wu, Zhenhai Lu, Junzhong Lin, Zhizhong Pan	2
11	Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer 2020 ·Cancer Immunology Research ·Hong-Wei Sun, Jing Chen, Wenchao Wu, Yanyan Yang, (unknown), Xing-Juan Yu, Haitian Chen, Zilian Wang, Xiaojun Wu, Limin Zheng	20
12	Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals 2020 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Weiwei Xiao, Xiaohao Wang, Haiyang Chen, (unknown), Qiaoxuan Wang, Hui Chang, Xiaojun Wu, Peirong Ding, Zhizhong Pan, Xiang‐Bo Wan, Yong Bao, (unknown)	7
13	Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients 2017 ·Journal of Thoracic Oncology ·Mian Xie, Xiaojun Wu, Fang Wang, Jinjun Zhang, Xiaosong Ben, Jiexia Zhang, Xiaoxiang Li	39
14	The Prognostic Significance of Notch1 and Fatty Acid Binding Protein 7 (FABP7) Expression in Resected Tracheobronchial Adenoid Cystic Carcinoma: A Multicenter Retrospective Study 2017 ·Cancer Research and Treatment ·Mian Xie, Xiaojun Wu, (unknown), Chaosheng He, Shenhai Wei, (unknown), (unknown), Yingying Gu	13
15	Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells 2017 ·Molecular Medicine Reports ·Qingjian Ou, Xiaojun Wu, Jianhong Peng, Rongxin Zhang, (unknown), Jiang Wu, Lin Zhang, Zhizhong Z. Pan, Desen Wan, Yujing Fang	3
16	Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes 2017 ·Chinese Journal of Cancer ·Jianhong Peng, Qingjian Ou, Xiaojun Wu, Rongxin Zhang, Qian Zhao, Jiang Wu, Zhenhai Lu, Desen Wan, Zhizhong Pan, Yujing Fang	23
17	Clinical study of bevacizumab combined with preoperative chemotherapy for colorectal cancer patients with liver metastases 2016 ·Zhenhai Lu, Fulong Wang, Jianhong Peng, Yunfei Yuan, Jiang Wu, Yuhong Li, Xiaojun Wu, (unknown), Peirong Ding, Li Li, Desen Wan, Zhizhong Pan	0
18	Comparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis 2016 ·OncoTargets and Therapy ·Zhansong Zhou, Xiaojun Wu, Yi Zhi, Peng He, Xiaozhou Zhou, Ji Zheng, Zhiwen Chen	4
19	Expression and clinical significance of high mobility group box 1 in stage IIIB colon cancer 2011 ·Jiefangjun yixue zazhi ·Ruiqing Peng, Chunyan Li, (unknown), Xing-Juan Yu, Xiaojun Wu, Xing Zhang, Zhizhong Pan, Xiaoshi Zhang	1
20	Expression of beclin-1, an autophagy-related protein, in stage III B colon cancer and its relationship with prognosis 2009 ·Clinical Oncology and Cancer Research ·(unknown), Chunyan Li, Ruiqing Peng, Haiying Wang, Xiaojun Wu, Desen Wan, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact